Your browser doesn't support javascript.
loading
Increase of TREM2 during Aging of an Alzheimer's Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis.
Brendel, Matthias; Kleinberger, Gernot; Probst, Federico; Jaworska, Anna; Overhoff, Felix; Blume, Tanja; Albert, Nathalie L; Carlsen, Janette; Lindner, Simon; Gildehaus, Franz Josef; Ozmen, Laurence; Suárez-Calvet, Marc; Bartenstein, Peter; Baumann, Karlheinz; Ewers, Michael; Herms, Jochen; Haass, Christian; Rominger, Axel.
Afiliação
  • Brendel M; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München Munich, Germany.
  • Kleinberger G; Department of Biochemistry, Biomedical Center (BMC), Ludwig-Maximilians-Universität MünchenMunich, Germany; Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-Universität MünchenMunich, Germany.
  • Probst F; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München Munich, Germany.
  • Jaworska A; DZNE-German Center for Neurodegenerative DiseasesMunich, Germany; Laboratory of Neurodegeneration, International Institute of Molecular and Cell BiologyWarsaw, Poland.
  • Overhoff F; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München Munich, Germany.
  • Blume T; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München Munich, Germany.
  • Albert NL; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München Munich, Germany.
  • Carlsen J; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München Munich, Germany.
  • Lindner S; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München Munich, Germany.
  • Gildehaus FJ; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München Munich, Germany.
  • Ozmen L; Roche Pharma Research and Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. Basel, Switzerland.
  • Suárez-Calvet M; Department of Biochemistry, Biomedical Center (BMC), Ludwig-Maximilians-Universität MünchenMunich, Germany; DZNE-German Center for Neurodegenerative DiseasesMunich, Germany.
  • Bartenstein P; Department of Nuclear Medicine, Ludwig-Maximilians-Universität MünchenMunich, Germany; Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-Universität MünchenMunich, Germany.
  • Baumann K; Roche Pharma Research and Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. Basel, Switzerland.
  • Ewers M; DZNE-German Center for Neurodegenerative Diseases Munich, Germany.
  • Herms J; Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-Universität MünchenMunich, Germany; DZNE-German Center for Neurodegenerative DiseasesMunich, Germany.
  • Haass C; Department of Biochemistry, Biomedical Center (BMC), Ludwig-Maximilians-Universität MünchenMunich, Germany; Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-Universität MünchenMunich, Germany; DZNE-German Center for Neurodegenerative DiseasesMunich, Germany.
  • Rominger A; Department of Nuclear Medicine, Ludwig-Maximilians-Universität MünchenMunich, Germany; Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-Universität MünchenMunich, Germany.
Front Aging Neurosci ; 9: 8, 2017.
Article em En | MEDLINE | ID: mdl-28197095
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Front Aging Neurosci Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Front Aging Neurosci Ano de publicação: 2017 Tipo de documento: Article